Cohort Study: Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women with Breast Cancer
21 Feb, 2020 | 10:35h | UTCAromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study – Circulation (free for a limited period)